Morcellators Market Size, Share & Industry Analysis, By Products (Manual Morcellators, Power Morcellators), By Application (Laparoscopy, Hysterectomy, Uterine Myomectomy, Others), By End-User (Hospitals & Ambulatory Surgery Centres, Specialty Clinics, Others) and Regional Forecast, 2024-2032

Morcellation refers to cutting of tissues into smaller pieces. Morcellators are minimally invasive devices that are used during abdominal procedures such as fibroid removal and hysterectomy for cutting big sized tissues into smaller ones. It can be manual or power-driven. They provide a potential alternative to invasive and painful gynecological procedures. Increasing patient awareness has resulted in increasing demand for minimally invasive procedures, which in turn is favoring the market.

Rising number of hysterectomy and laparoscopy procedures, favorable health reimbursement, and increasing prevalence of uterine fibroid are the major factors driving the growth of the market. According to the National Women’s Health Network, approximately 600,000 hysterectomies are performed annually in the U.S. This coupled with technological advancements and rising geriatric population is anticipated to boost the market during the forecast period. Furthermore, shift towards minimally invasive surgeries is another important factor which is expected to aid in the market growth.

However, increasing cases of uterine cancer after morcellation is one of the key factors that may hinder the growth of the market. The FDA stated that 1 in every 350 women undergoing morcellation for myomectomy or hysterectomy might develop undiagnosed uterine cancer. This is expected to negatively impact the demand for morcellators. 

Market Segmentation:

Globally, the morcellators market can be segmented on the basis of product type, application, end user, and region. Based on the product type, the market can be segmented into power morcellators and manual morcellators. The power morcellators segment can be further bifurcated into laparoscopic morcellators and hysteroscopic morcellators. On the basis of application, the market can be segmented into laparoscopy, hysterectomy, uterine myomectomy, and others. In terms of end-users the market can be segmented into hospitals & ambulatory surgery centres, specialty clinics, and others.

Geographically, the morcellators market can be segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa.

Key Players Covered:

Some of the major companies that are present in the morcellators market are Medtronic, Olympus Corporation, Johnson & Johnson Services, Inc., Cook, KARL STORZ SE & Co. KG, Lumines, BOWA-electronic GmbH & Co. KG, and other prominent players.

Key Insights:

• Number of Hysterectomy Surgery by Key Countries/Region


• Regulatory and Reimbursement Overview by Key Countries/Region


• New Product Launches


• Key Industry Developments Mergers, Acquisitions, and Partnerships

Regional Analysis:

Geographically, the morcellators market can be segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is expected to account for the maximum portion of the market in 2019 owing to the increasing number of hysterectomies, rising adoption of morcellators in ambulatory surgery centers, and new product launches. In November 2016, Olympus Corporation announced FDA clearance for laparoscopic PK Morcellator in the U.S. This is likely to foster the market in North America. In Europe, the demand for morcellators is poised to surge owing to the favorable health reimbursement, and the rising prevalence of uterine fibroid. In Asia Pacific, the market is anticipated to witness a remarkable growth due to the rising geriatric population, increasing number of gynecological procedures, and technological advancements to make morcellators safer. In the Middle East and Africa and Latin America, the market is projected to augment owing to the rising patient pool, rising awareness regarding women’s health, and improving health spending.

Segmentation

Morcellators Market Industry Developments

• In November 2016, Olympus Corporation announced FDA 510(k) clearance for laparoscopic PK Morcellator in the U.S. The device will be used as a part of Olympus Contained Tissue Extraction System.


• In May 2016, Medtronic acquired the gynaecology business of Smith & Nephew plc which included a range of power morcellators namely Truclear. Truclear is considered to be a safer option over its competitor’s products.